Patients with congenital DNAJC12 deficiency present monoamine neurotransmitter decline and heterogenous clinical spectrum, including hyperphenylalaninemia and parkinsonism of varying severity, spanning from L-Dopa-responsive dystonia to severe neurodevelopmental delay and intellectual disability16,21. The gene discussed is DNAJC12; the disease is Hyperphenylalaninemia.